{"changes":[{"companyHref":"/c/obsidiantx-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"obsidiantx.com","fact":"company:added","name":"Obsidian Therapeutics","new":"added","old":"","publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"obsidiantx-com","status":"sourced","url":"https://whoraisedwhat.com/c/obsidiantx-com"}],"country":"","description":"New class of regulated cell and gene therapies NASDAQ: OBX (2026)","domain":"obsidiantx.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":["atlas-venture"],"lat":null,"lng":null,"location":null,"name":"Obsidian Therapeutics","nameSource":{"publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},"people":[],"rounds":[],"slug":"obsidiantx-com","sources":[{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":null,"techStack":[],"totalRaisedUsd":null,"updatedAt":"2026-10-03"}